CXCL12 expression as a prognostic marker in 40 low-grade oligodendrogliomas and oligoastrocytomas

被引：0
|
作者：
Pollo, B. [1 ]
Maderna, E. [1 ]
Calatozzolo, C. [1 ]
Gelati, M. [1 ]
Marras, C. [1 ]
Silvani, A. [1 ]
Croci, D. [1 ]
Boiardi, A. [1 ]
Salmaggi, A. [1 ]
机构：
[1] Ist Nazl Neurol C Besta, Milan, Italy
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [1] Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas
    Calatozzolo, Chlara
    Maderna, Ernanuela
    Pollo, Bianco
    Gelati, Maurizio
    Marras, Carlo
    Silvani, Antonio
    Croci, Danilo
    Boiardi, Arnerigo
    Salmaggi, Andrea
    CANCER BIOLOGY & THERAPY, 2006, 5 (07) : 827 - 832
  • [2] Chemotherapy with PCV for low grade nonenhancing oligodendrogliomas and oligoastrocytomas
    Soffietti, R
    Rudà, R
    Borgognone, M
    Schiffer, D
    NEUROLOGY, 1999, 52 (06) : A423 - A424
  • [3] Prognostic factors in children and adolescents with low-grade oligodendrogliomas
    Bowers, DC
    Mulne, AF
    Weprin, B
    Bruce, DA
    Shapiro, K
    Margraf, LR
    PEDIATRIC NEUROSURGERY, 2002, 37 (02) : 57 - 63
  • [4] Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas
    Vaquero, J
    Zurita, M
    Morales, C
    Coca, S
    BRITISH JOURNAL OF NEUROSURGERY, 2001, 15 (03) : 247 - 250
  • [5] CHEMOTHERAPY FOR LOW-GRADE OLIGODENDROGLIOMAS
    PALEOLOGOS, NA
    VICK, NA
    KACHORIS, JP
    ANNALS OF NEUROLOGY, 1994, 36 (02) : 294 - 295
  • [6] CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of progression
    Pfeffer, U.
    Mirisola, V.
    Zuccarino, A.
    Bachmeier, B.
    Sormani, M. P.
    Falter, J.
    Nerlich, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 141 - 141
  • [7] Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma
    Akishima-Fukasawa, Yuri
    Nakanishi, Yukihiro
    Ino, Yoshinori
    Moriya, Yoshihiro
    Kanai, Yae
    Hirohashi, Setsuo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 202 - 210
  • [8] Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions
    Hoang-Xuan, K
    Capelle, L
    Kujas, M
    Taillibert, S
    Duffau, H
    Lejeune, J
    Polivka, M
    Crinière, E
    Marie, Y
    Mokhtari, K
    Carpentier, AF
    Laigle, F
    Simon, JM
    Cornu, P
    Broët, P
    Sanson, M
    Delattre, JY
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3133 - 3138
  • [9] CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: A single-institution study in 50 patients
    Salmaggi, A
    Gelati, M
    Pollo, B
    Marras, C
    Silvani, A
    Balestrini, MR
    Eoli, M
    Fariselli, L
    Broggi, G
    Boiardi, A
    JOURNAL OF NEURO-ONCOLOGY, 2005, 74 (03) : 287 - 293
  • [10] CXCL12 Expression is Predictive of a Shorter Time to Tumor Progression in Low-Grade Glioma: A Single-Institution Study in 50 Patients
    A. Salmaggi
    M. Gelati
    B. Pollo
    C. Marras
    A. Silvani
    M. R. Balestrini
    M. Eoli
    L. Fariselli
    G. Broggi
    A. Boiardi
    Journal of Neuro-Oncology, 2005, 74 : 287 - 293
12345